Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955008034> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2955008034 endingPage "4390" @default.
- W2955008034 startingPage "4390" @default.
- W2955008034 abstract "Abstract We previously reported that dietary daidzein, a soy isoflavone, increased breast cancer progression in a nude mouse model of breast cancer metastasis. Further studies indicated that equol, a metabolite of the soy isoflavone daidzein is responsible for the cancer promoting effects of soy isoflavones in breast cancer cells in vitro. We reported that equol increases the expression of the eukaryotic protein synthesis initiation factor eIF4G1, and the transcription factor c-Myc. Increased eIF4G in response to equol resulted in the non-canonical protein synthesis of pro-cancer molecules such as Cyclin D, Bcl-XL, p120, matrix metalloproteinases, etc., as confirmed by ribosome profiling and eIF4G1 knockdown studies. This study tested the hypothesis that equol promoted breast cancer progression via eIF4G1 upregulation. Immunocompromised nude mice were used to establish mammary fatpad tumors from human metastatic breast cancer cells expressing eIF4G1 knockdowns via a Tetracycline-inducible promoter. Oral gavage of 50 mg/kg BW Doxycycline 3X a week for 4 weeks was enough to knockdown eIF4G1 expression by ~80%. Therefore, one week following tumor establishment, the mice were treated with vehicle (90% corn oil, 10% ethanol), equol, Doxycycline or, equol and Doxycycline. Data show that as expected, equol treatment increased tumor growth relative to vehicle treatment. Moreover, eIF4G1 knockdown abolished the effect of equol on tumor growth. Interestingly, the effect of eIF4G1 knockdown on mammary tumor growth was not evident until 55 days of doxycycline treatment. Therefore, we tested the cell and tumor lysates for potential expression of the eIF4G1 isoform Dap5 when eIF4G1 is knocked out. Dap5 protein was expressed in eIF4G1 knockdown cells and was increased by equol treatment, indicating that Dap5 may compensate for eIF4G1 knockdown by inducing alternative cap-mediated protein synthesis. In conclusion, the cancer promoting effect of equol is abolished in breast tumors where eIF4G1 expression was stably knocked down, thus, validating our hypothesis that equol increases breast cancer progression via upregulation of eIF4G1 dependent protein synthesis initiation. Citation Format: Ailed M. Cruz-Collazo, Columba De la Parra, Robert Schneider, Suranganie Dharmawardhane. Dietary soy isoflavone equol promotes breast cancer progression via regulation of protein synthesis initiation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4390." @default.
- W2955008034 created "2019-07-12" @default.
- W2955008034 creator A5005452592 @default.
- W2955008034 creator A5013914918 @default.
- W2955008034 creator A5026855277 @default.
- W2955008034 creator A5054895434 @default.
- W2955008034 date "2019-07-01" @default.
- W2955008034 modified "2023-09-27" @default.
- W2955008034 title "Abstract 4390: Dietary soy isoflavone equol promotes breast cancer progression via regulation of protein synthesis initiation" @default.
- W2955008034 doi "https://doi.org/10.1158/1538-7445.am2019-4390" @default.
- W2955008034 hasPublicationYear "2019" @default.
- W2955008034 type Work @default.
- W2955008034 sameAs 2955008034 @default.
- W2955008034 citedByCount "0" @default.
- W2955008034 crossrefType "journal-article" @default.
- W2955008034 hasAuthorship W2955008034A5005452592 @default.
- W2955008034 hasAuthorship W2955008034A5013914918 @default.
- W2955008034 hasAuthorship W2955008034A5026855277 @default.
- W2955008034 hasAuthorship W2955008034A5054895434 @default.
- W2955008034 hasConcept C121608353 @default.
- W2955008034 hasConcept C126322002 @default.
- W2955008034 hasConcept C134018914 @default.
- W2955008034 hasConcept C173396325 @default.
- W2955008034 hasConcept C190283241 @default.
- W2955008034 hasConcept C199835354 @default.
- W2955008034 hasConcept C2776187077 @default.
- W2955008034 hasConcept C2778298627 @default.
- W2955008034 hasConcept C2779256057 @default.
- W2955008034 hasConcept C2779705811 @default.
- W2955008034 hasConcept C2780955279 @default.
- W2955008034 hasConcept C2781262405 @default.
- W2955008034 hasConcept C29537977 @default.
- W2955008034 hasConcept C502942594 @default.
- W2955008034 hasConcept C530470458 @default.
- W2955008034 hasConcept C55493867 @default.
- W2955008034 hasConcept C71924100 @default.
- W2955008034 hasConcept C86803240 @default.
- W2955008034 hasConceptScore W2955008034C121608353 @default.
- W2955008034 hasConceptScore W2955008034C126322002 @default.
- W2955008034 hasConceptScore W2955008034C134018914 @default.
- W2955008034 hasConceptScore W2955008034C173396325 @default.
- W2955008034 hasConceptScore W2955008034C190283241 @default.
- W2955008034 hasConceptScore W2955008034C199835354 @default.
- W2955008034 hasConceptScore W2955008034C2776187077 @default.
- W2955008034 hasConceptScore W2955008034C2778298627 @default.
- W2955008034 hasConceptScore W2955008034C2779256057 @default.
- W2955008034 hasConceptScore W2955008034C2779705811 @default.
- W2955008034 hasConceptScore W2955008034C2780955279 @default.
- W2955008034 hasConceptScore W2955008034C2781262405 @default.
- W2955008034 hasConceptScore W2955008034C29537977 @default.
- W2955008034 hasConceptScore W2955008034C502942594 @default.
- W2955008034 hasConceptScore W2955008034C530470458 @default.
- W2955008034 hasConceptScore W2955008034C55493867 @default.
- W2955008034 hasConceptScore W2955008034C71924100 @default.
- W2955008034 hasConceptScore W2955008034C86803240 @default.
- W2955008034 hasIssue "13_Supplement" @default.
- W2955008034 hasLocation W29550080341 @default.
- W2955008034 hasOpenAccess W2955008034 @default.
- W2955008034 hasPrimaryLocation W29550080341 @default.
- W2955008034 hasRelatedWork W1178620687 @default.
- W2955008034 hasRelatedWork W1898962100 @default.
- W2955008034 hasRelatedWork W2054276370 @default.
- W2955008034 hasRelatedWork W2114379216 @default.
- W2955008034 hasRelatedWork W2133400920 @default.
- W2955008034 hasRelatedWork W2508279739 @default.
- W2955008034 hasRelatedWork W3214516457 @default.
- W2955008034 hasRelatedWork W4313447728 @default.
- W2955008034 hasRelatedWork W4386704863 @default.
- W2955008034 hasRelatedWork W4739994 @default.
- W2955008034 hasVolume "79" @default.
- W2955008034 isParatext "false" @default.
- W2955008034 isRetracted "false" @default.
- W2955008034 magId "2955008034" @default.
- W2955008034 workType "article" @default.